I don't know - Holgate's talk was very interesting.
Sonya Chowdhury tweeted it:
https://twitter.com/SonyaChowdhury/with_replies
UK Research Collaborative Conference in Newcastle: 13th - 14th October
- Thread starter charles shepherd
- Start date
I don't know - Holgate's talk was very interesting.
Sonya Chowdhury tweeted it:
https://twitter.com/SonyaChowdhury/with_replies
I don't understand why they don't point the camera at the slides rather than the speaker, it's too jerky to watch and out of synch with the audio anyway.
It's a failure on the part of the sound tech who should have just gone up to the stage and moved the microphone (or even better to ask speakers beforehand to do quick sound checks and have everything in place for when they start)
Unfortunate that her psych bias is coming through very strongly,eg trying to claim that Prof Montoya was passionate about including psychiatrists (not what he said) and that she'll put questions to the panel - but not about PACE because we musn't be "negative" about ANY research
I couldn't hear very well what he said (a combo of sound quality and his accent) - so he didn't say that?
eafw said:
Did she say that? I haven't read all her tweets.
Cheshire
Senior Member
- Messages
- 1,129
Dr Montoya said he even had a psychiatrist in his team, and that he clearly stated there was no way this illness could be psychiatric.
His comment about inclusivity was in the context of patient populations, young, severe etc and separately he said that they included psychs in their team but only so they could assess patients and confirm that this was NOT a mental health problem that was being dealt with. Her tweets in this convo misrepresent that:
Then
Oh... I see what you mean...
me/cvs nieuws on Twitter said:
Sonya Chowdhury on Twitter said:
I don't think that's a sound position. If one has a negative view of the PACE trial (or any other research) that's well-founded in the design or data, I don't see any problem at all with reflecting that negative view in a sensible question at a scientific conference. People have a lot of well-justified questions about PACE, and science moves forward partly by critiquing stuff that's poorly done or misleadingly spun.
But perhaps a well-phrased question might make it through, as long as it's relevant to proceedings.
I hope Sonya will reconsider the position that she's taken there.
Then I agree - it would have been better if she'd made the context clear, given the history of the nature of psychiatric involvement in the UK.
It seems to be possible to tweet replies to her, though, to things that people disagree with. Don't know if anyone wants to tweet a clarification of what Dr Montoya meant?
@Jonathan Edwards, are you at the conference?
This UK CMRC "Grand Challenge" thing that Prof Holgate mentioned sounded interesting - he was talking about setting up a workshop to bring the relevant stakeholders (including charities) together to formulate an action plan for "pan-UK approach to subphenotype, collect samples, integrate data, pathway analyses" (from SC's tweet - I didn't make notes).
Here's a google result from that hashtag, not sure if it's the best way to do it:
https://twitter.com/search?q=#cmrc2015
https://twitter.com/search?q=#cmrc2015
Simon
Senior Member
- Messages
- 3,789
- Location
- Monmouth, UK
This is hugely amibitous, and will be very expensive. And is probably just what mecfs needs. The idea is to get a big cohort of patients and collect and analyse a mass of data inclluding genes, gene expression, proteins, immune types and metabolism. The hope is that such a huge and widespread dataset will reveal true subgroups amongst patients, each with separate causal pathways - as a way of homing in on causes and then treatments.
He said the same approach in asthma led to this 'single' disease being divided into different subgroups, each potentially responding to different treatments. Here's details of a similar approach with bowel cancer
CRUK Oxford Centre | £5 Million Stratified Medicine Programme Launched to Personalise Care For Bowel Cancer Patients
I blogged about the idea here
A Dozen Different Diseases? Stephen Holgate Calls for Radical Change in ME/CFS Research
The Wellcome Trust have recently joined the CMRC and this might be just the kind of study to pique their interest, and hopefully open their coffers.
Last edited:
Katie Druce, a post-doc research assistant in epidemiology, is also tweeting from the conference:
https://twitter.com/katie_druce
https://twitter.com/katie_druce
Who was that saying that we also need a big Valcyte study in the UK? Was that Holgate?
What I like about Holgate (if that's him - I'm rubbish at recognising faces) is that he keeps coming up with "what we should do next" ideas and immediately names the MRC funding mechanism that will get it done.
Very lucky to have someone who understands the system and is thinking big. I bet that will be very attractive to the MRC - these big plans.
I wonder what the funding announcement will be, later on today...
What I like about Holgate (if that's him - I'm rubbish at recognising faces) is that he keeps coming up with "what we should do next" ideas and immediately names the MRC funding mechanism that will get it done.
Very lucky to have someone who understands the system and is thinking big. I bet that will be very attractive to the MRC - these big plans.
I wonder what the funding announcement will be, later on today...